rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1995-3-8
|
pubmed:abstractText |
To assess red blood cell deformability (RCD) in patients with rheumatoid arthritis (RA) without extraarticular manifestations and in RA with vasculitic complications (RV), and to assess whether in vitro dipyridamole improves RCD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
248-53
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7848316-Adult,
pubmed-meshheading:7848316-Aged,
pubmed-meshheading:7848316-Arthritis, Rheumatoid,
pubmed-meshheading:7848316-Dipyridamole,
pubmed-meshheading:7848316-Erythrocyte Deformability,
pubmed-meshheading:7848316-Female,
pubmed-meshheading:7848316-Filtration,
pubmed-meshheading:7848316-Humans,
pubmed-meshheading:7848316-Leukocyte Count,
pubmed-meshheading:7848316-Male,
pubmed-meshheading:7848316-Middle Aged,
pubmed-meshheading:7848316-Platelet Count,
pubmed-meshheading:7848316-Pressure,
pubmed-meshheading:7848316-Vasculitis
|
pubmed:year |
1995
|
pubmed:articleTitle |
Reduced red blood cell deformability in patients with rheumatoid vasculitis. Improvement after in vitro treatment with dipyridamole.
|
pubmed:affiliation |
Department of Medicine, Queen Mary Hospital, University of Hong Kong, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|